Bicara Therapeutics (BCAX) Treasury Shares (2023 - 2026)

Name: Bicara Therapeutics (BCAX) Treasury Shares (2023 - 2026) | Business Quant
Creator: Business Quant

Bicara Therapeutics posted quarterly Treasury Shares of $9361.0 for Q1 2026, little changed on a QoQ basis from $9361.0 in Q4 2025.

Bicara Therapeutics (BCAX) has 4 years of Treasury Shares data on file, last reported at $9361.0 in Q1 2026.

For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $9361.0; the trailing twelve-month figure through Mar 2026 stood at $9361.0 (changed N/A YoY), and the FY2025 full-year result was $9361.0, changed 0.0% from the prior year.
Treasury Shares for Q1 2026 stood at $9361.0, roughly flat from $9361.0 in the prior quarter.
Across five years, Treasury Shares topped out at $47199.0 in Q4 2023 and bottomed at $6947.0 in Q3 2024.
The 4-year median for Treasury Shares is $9361.0 (2024), against an average of $16445.8.
The widest annual swing landed in 2024, when Treasury Shares plunged 80.17%; it then changed 0.0% in 2025.
A 4-year view of Treasury Shares shows it stood at $47199.0 in 2023, then slumped by 80.17% to $9361.0 in 2024, then changed by 0.0% to $9361.0 in 2025, then changed by 0.0% to $9361.0 in 2026.
The last three Treasury Shares figures came in at $9361.0 (Q1 2026), $9361.0 (Q4 2025), and $9361.0 (Q4 2024), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	265,401.92
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	700,000.00
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	34.70 Mn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Bicara Therapeutics	1.25 Bn	1.25 Bn	-	9,361.00

Download Data 🔒